The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022

Cardiovascular disease (CVD) has become a huge challenge for the global public health system due to its high morbidity, mortality and severe economic burden. In recent years, angiotensin receptor neprilysin inhibitor (ARNI), a new class of drugs, has shown good therapeutic effects on CVD patients in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xia, Li, Yumeng, Shi, Shuqing, Lv, Jiayu, Wang, Yajiao, Zheng, Haoran, Mao, Xinxin, Wu, Huaqin, Zhang, Bingxuan, Song, Qingqiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114353/
https://www.ncbi.nlm.nih.gov/pubmed/35600466
http://dx.doi.org/10.3389/fcvm.2022.899235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114353/
https://www.ncbi.nlm.nih.gov/pubmed/35600466
http://dx.doi.org/10.3389/fcvm.2022.899235

Ejemplares similares